Hims & Hers stock drops 7% despite higher guidance: what went wrong?
Covered by 1 source · 1 article
Shares of Hims & Hers Health fell more than 7% in premarket trading on Tuesday after the telehealth company reported a wider-than-expected second-quarter loss, as investments in branded GLP-1 weight-loss treatments and international expansi…
Covered by
